טוען...
CMET-27. OUTCOMES OF LUNG CANCER PATIENTS WITH LEPTOMENINGEAL METASTASES IN THE TARGETED THERAPY ERA
BACKGROUND: Improvements in detection and molecular characterization of leptomeningeal metastasis from lung cancer (LC-LM) coupled with cerebrospinal fluid (CSF)-penetrating targeted therapies have altered disease management. In this new era, outcomes of patients with LC-LM are not well-defined. Thi...
שמור ב:
| הוצא לאור ב: | Neuro Oncol |
|---|---|
| Main Authors: | , , , , , , , |
| פורמט: | Artigo |
| שפה: | Inglês |
| יצא לאור: |
Oxford University Press
2018
|
| נושאים: | |
| גישה מקוונת: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6216926/ https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/neuonc/noy148.239 |
| תגים: |
הוספת תג
אין תגיות, היה/י הראשונ/ה לתייג את הרשומה!
|